SYDNEY, Australia, Aug. 4 /Xinhua-PRNewswire-FirstCall/ -- Specialist pharmaceutical company Pharmaxis Ltd will release its Quarterly Report to Shareholders and the Preliminary Final Report for the 2006 Financial Year on the afternoon of Tuesday 8th August. Dr Alan Robertson will host an investor teleconference the following morning to review the quarter and answer investor questions.
The teleconference will be at 8.30am (AEST), on Wednesday 9th August (Tuesday 8th August, at 6.30pm (EDT/New York), 3.30pm (PDT/California).
Telephone access (toll free) details are below: -- Australia: 1800 131 617 -- USA/Canada: 1866 746 2596 -- Online (global access): http://services.choruscall.com/links/pharmaxis060809.html
A recording of the conference will be available on the Pharmaxis website home page 3 hours later.
To find out more about Pharmaxis, go to http://www.pharmaxis.com.au . CONTACT: Jane Sugden Pharmaxis Investor Relations and Communications Tel: +61-2-9454-7230 Fax: +61-2-9451-3622 Website: www.pharmaxis.com.au Released through: United States: Brandon Lewis Trout Group Tel: +1-212-477-9007 Email: blewis@troutgroup.com Australia: Ashley Rambukwella Financial & Corporate Relations Pty Ltd. Tel: +61-2-8264-1004 or +61-407-231-282 Email: a.rambukwella@fcr.com.au
Pharmaxis Ltd
CONTACT: Jane Sugden of Pharmaxis, +61-2-9454-7230, +61-2-9451-3622; orBrandon Lewis of Trout Group for Pharmaxis, +1-212-477-9007, orblewis@troutgroup.com; or Ashley Rambukwella of Financial & CorporateRelations Pty Ltd. for Pharmaxis, +61-2-8264-1004, or +61-407-231-282, ora.rambukwella@fcr.com.au
Web site: http://www.pharmaxis.com.au/
